Acarix AB ACARIX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- SEK 0.24
- Day Range
- SEK 0.23–0.24
- 52-Week Range
- SEK 0.18–0.80
- Bid/Ask
- SEK 0.23 / SEK 0.23
- Market Cap
- SEK 184.18 Mil
- Volume/Avg
- 1.6 Mil / 4.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 17.89
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Acarix AB is a Swedish medical technology company that develops innovative solutions for rapid AI-based exclusion of coronary artery disease (CAD). The CE-marked CADScor System, which has also received DeNovo approval from the FDA, is intended for patients experiencing chest pain with suspected coronary artery disease and is designed to help reduce millions of cases of unnecessary, invasive, and costly diagnostics. The CADScor System uses advanced acoustics and AI technology to non-invasively rule out CAD in less than 10 minutes, with at least 96% certainty.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 14
- Website
- https://www.acarix.com
Valuation
|
Metric
|
ACARIX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 3.34 |
Price/Sales | 17.89 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ACARIX
|
|---|---|
Quick Ratio | 3.42 |
Current Ratio | 4.57 |
Interest Coverage | −588.92 |
Quick Ratio
ACARIX
Profitability
|
Metric
|
ACARIX
|
|---|---|
Return on Assets (Normalized) | −143.35% |
Return on Equity (Normalized) | −183.59% |
Return on Invested Capital (Normalized) | −182.84% |
Return on Assets
ACARIX
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Bshvcnss | Nmhccp | $185.4 Bil | |
SYK
| Stryker Corp | Jwzzynvn | Qqh | $128.2 Bil | |
BSX
| Boston Scientific Corp | Mcypzrh | Jbrsth | $107.7 Bil | |
MDT
| Medtronic PLC | Dvfgtrlv | Zngdmg | $105.2 Bil | |
DXCM
| DexCom Inc | Tcqctpnpsl | Vpw | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Lpxjcfmsf | Vsdfhwj | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Lyfkmtry | Bqp | $24.6 Bil | |
ALGN
| Align Technology Inc | Tjnmvlqr | Bwcnkj | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Vzzvrxh | Sgvhfd | $19.0 Bil | |
PODD
| Insulet Corp | Dnbjkwvmq | Xfnljvf | $11.5 Bil |